Travers, Matthew David — Insider Profile

Insider Profile

Travers, Matthew David

🔒 Follow — get an alert on any new filing

$STN

Companies Filed At

Open-Market Buys (2yr)

$33K

Buy Value (2yr, open-market)

Jun 19, 2026

Most Recent Trade

Credibility
Score

100%

Hit Rate

+3.6%

Avg 90d Return

+3.6%

Median 90d Return

Evaluated Trades

+3.6%

Best Trade

+3.6%

Worst Trade

Hit rate and returns are based on 2 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.

Cross-Company Track Record

THIN HISTORY

—

Hit Rate · 90d

-11.1%

Median Alpha · 90d

Closed Buys Evaluated

Beat XIU

All-insider base rate: 59% hit rate · +1.3% mean alpha (n=11504)

size concentrated

Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.

Research 1 closed buys with individual return outcomes available on the Research plan.

Date	Company	Role	Nature	Dir.	Shares	Price	Value	Score
Jun 19, 2026	$STN Stantec	—	Other	Sell	311	$110.11	$34K	63
Jun 19, 2026	$STN Stantec	—	Other	Sell	1,240	$136.54	$169K	63
May 19, 2026	$STN Stantec	—	Comp. Grant	Buy	2,980	—	—	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	22	$139.96	$3K	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	7	$141.23	$989	63
Dec 31, 2025	$STN Stantec	—	Plan / DRIP	Buy	116	$102.50	$12K	63
Dec 03, 2025	$STN Stantec	—	Open Market	Buy	350	$94.86	$33K	63
Jun 20, 2025	$STN Stantec	—	Other	Sell	414	$133.69	$55K	63
Jun 20, 2025	$STN Stantec	—	Other	Sell	1,652	$143.72	$237K	63
May 20, 2025	$STN Stantec	—	Comp. Grant	Buy	529	$136.29	$72K	63
May 20, 2025	$STN Stantec	—	Comp. Grant	Buy	1,234	—	—	63
Mar 29, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Mar 29, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Mar 29, 2025	$STN Stantec	—	Other	Sell	—	—	—	63
Mar 29, 2025	$STN Stantec	—	Other	Sell	—	—	—	63

Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.